Top news of the week: 18.08.2020.
Initial public offering, Reach, Dot-com bubble, Heart, Antibody, Biotechnology
Startups
RT @MassBio: MassBio's 2020 Industry Snapshot shows MA remains an R&D powerhouse, with #biotech R&D jobs reaching 46,000 in 2019, an increase of 18% from 2018. Download our report to learn more: https://t.co/nzCATs7AxP
OpenIndustry Snapshot
The Massachusetts biopharma industry experienced the highest year-over-year employment growth in over a decade.
How a protein implicated in Alzheimer’s could enhance cancer immunotherapy https://t.co/vI8U1zkN6h https://t.co/5XhtkjlYAr
OpenHow a protein implicated in Alzheimer’s could enhance cancer immunotherapy
Variants of TREM2, a receptor expressed by immune cells, have been linked to the development of Alzheimer’s disease. Now scientists at Washington University School of Medicine have ...
Eleusis sheds light on psychedelics that relieve asthma in rats with no mental effects https://t.co/459f9Uh4zl https://t.co/FS41ZoTTOV
OpenEleusis sheds light on psychedelics that relieve asthma in rats with no mental effects
A team of researchers at Eleusis discovered that structural characteristics of the 2C-H class of psychedelics help to control inflammation in rat models of asthma without causing behavioral ...
RT @adamfeuerstein: CureVac’s $CVAC value soars after IPO, as #COVID19 vaccine manufacturers become biotech’s hottest... https://t.co/rWOI7mvpZZ via @damiangarde
OpenCureVac’s value soars after IPO, as Covid-19 vaccine manufacturers become biotech’s hottest companies
CureVac, headquartered in Germany, saw its share price nearly triple within hours of an initial public offering on Friday.
RT @MassBio: MassBio recently kicked off the summer cycle & a new #COVID19 cycle of its MassCONNECT PI program, the only program in MA solely dedicated to serving the needs of #PrincipalInvestigators (PIs) in #LifeSciences. Learn more about each cycle's participants: https://t.co/dyF19q6OUq
OpenMassBio® Welcomes 18 Principal Investigators to its MassCONNECT PI Summer and COVID-19 Cycles
MassBio® recently kicked off the summer and COVID-19 cycles of its MassCONNECT PI program, the only program in Massachusetts that is solely dedicated to serving the needs of Principal ...
RT @edyong209: This is an incredibly important story that I urge you to read.
By @alexismadrigal and @yayitsrob, who've been at the very forefront of our pandemic coverage.
https://t.co/CxN1YZMj1Q
OpenThe Way Out
The U.S. has never had enough coronavirus tests. Now a group of epidemiologists, economists, and dreamers has a new plan to defeat the virus, even before a vaccine is found.
Without swift action to jumpstart antimicrobial innovation & improve the pipeline of new drugs, the world will soon find itself unprepared for another global health emergency. @koutterson & John Rex highlight the role of policy & how we can overcome this: https://t.co/4wCbtsbnX6
OpenWe need new antimicrobials to prevent the next infectious disease crisis
Imagine if scientists had seen Covid-19 coming years in advance yet did little to prepare for it. That's what's happening with the superbug crisis.
The reason there are more VC backed female CEOs this year
https://t.co/f5No5aQxE0 @MassBio @MALifeSciences @AllRaise @NewEnglandVC
OpenThe reason there are more VC backed female CEOs
And the surge in healthcare deals so far in 2020 is driving the increase in the number of female CEOs whose companies are receiving venture capital. Biopharma and healthcare IT …